|
市場調查報告書
全球藥品及生物科技產業CEO的全方位預測
CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry
|
全球藥品及生物科技產業CEO的全方位預測 是由出版商Frost & Sullivan在2009年07月所出版的。
這份英文市場調查報告書包含54 Pages 價格從美金6000起跳。
本報告書內容包括：藥品及生物科技產業的全球動向、技術、經濟、競爭、顧客、最佳實務典範等產業今後展望分析。內容綱要摘記如下：
第1章 全球藥品及生物科技產業
- 介紹
- 全球預測
- 全球預測
- 全球醫療實驗動向
- 從成熟市場到新興市場的轉換
- 產業整合預測
- 產業整合預測
- 因應變化的商業模式
- Pfizer及Wyeth的整合
- 醫療整合促進個性化發展
- 從業務委外到策略性委外合作的轉換促進LIMS標準化
- 技術預測
- 技術預測
- 口服癌症治療藥的重要性提高
- 基因體學的進歩促進醫療架構轉換
- 協助選擇最有發展潛力藥物的有效篩檢方法
- 疫苗市場的發展促進技術創新
- 基因療法
- 經濟預測
- 經濟預測
- 美國生物科技創投資金的投資在2002年陷入最低潮
- 不景氣使得生物科技相關新上市股票數減少
- 醫療費用增加
- 競爭預測
- 競爭預測
- 朝綜合解決方案提供企業發展
- 因應生物標記藥物開發及診斷藥開發的平台技術提供企業的重新定位
- 生物學名藥的發展改變產業環境
- 顧客預測
- 顧客預測
- 強勢的患者世代
- e-detailing的重要性增加
- 醫療旅遊
- 最佳實務典範預測
- 最佳實務典範預測
- 環保的化學發展行動
- 矚目高度潛在需求及特殊領域
- 發展中國家的低成本藥物
- 複合商業模式之利用
- Frost & Sullivan介紹
Abstract
This research service presents the CEO 360 Degree Perspective for the global
pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of
research from more than 50 Pharmaceutical research services generated by Frost
& Sullivan, customer research findings based on approximately 1,000 end-user
interviews approximately 50,000 hours of analyst research, in the last 2
years. Global healthcare analysts from Frost & Sullivan have contributed their
market knowledge to cover the most important issues that are relevant in the
healthcare industry today. The report also includes research findings from
econometric, advanced technology and several other business divisions of Frost
& Sullivan.
Table of Contents
1. PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRY
Introduction
- Title
- Disclaimer
- Certification
- Research Overview and Background
- 360 Degree Perspective and the Complex Business Universe
- Table of Contents
Global Perspective
- Global Perspective
- Shifting Global Clinical Trial Dynamics
- Shift In Growth From Mature Markets To Emerging Markets
Integrated Industry Perspective
- Integrated Industry Perspective
- Adaptation To Changing Business Models
- Consolidation of Pfizer and Wyeth
- Convergence of Healthcare Allows for Personalization
- Move from Transactional to Strategic Outsourcing Partnerships Encourages
Standardization of LIMS
Technology Perspective
- Technology Perspective
- Oral Oncology Drugs Increasing in Importance
- Advances in Genomics Promotes Healthcare Paradigm Shift
- Effective Screening Methods to Select the Most Promising Drug Candidates
- Growth of Vaccines Market Boosting Technology Innovation
- Gene Therapy Driving Market
Economic Perspective
- Economic Perspective
- Venture Capital Investment in U.S. Biotechnology has Decreased to Levels
Not Seen Since 2002
- Decreasing Number of Biotech IPO' s due to Economic Downturn
- Restructuring
- Continued Healthcare Spending Growth
Competitive Perspective
- Competitive Perspective
- Companies Transforming to Comprehensive Solution Providers
- Repositioning of Platform Technology Providers in Response to Biomarker
Discovery and Diagnostics Development
- Expansion of Biosimilars Alters Industry Landscape
Customer Perspective
- Customer Perspective
- Power Patient Generation
- eDetailing To Assume More Significance
- Medical Tourism - Emerging Hot Spots
Best Practices Perspective
- Best Practices Perspective
- Green Chemistry Initiatives
- Focus on Diseases with High Unmet Needs and Special Designations
- Lower Cost Drugs for Developing Countries
- Employing Hybrid Business Models
About Frost & Sullivan
|
